The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis. (2021)

First Author: Phillips AN

Attributed to: Blood borne viruses funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(21)00025-5

PubMed Identifier: 33770513

Publication URI: http://europepmc.org/abstract/MED/33770513

Type: Journal Article/Review

Volume: 9

Parent Publication: The Lancet. Global health

Issue: 5

ISSN: 2214-109X